NASDAQ: DERM
Journey Medical Corp Stock Ownership - Who owns Journey Medical?

Insider buying vs selling

Have Journey Medical Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Claude MaraouiPresident CEO2025-08-251,250,000$0.07
$81.25kBuy
Claude MaraouiPresident CEO2025-08-2510,877$7.47
$81.25kSell

1 of 1

DERM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DERM insiders and whales buy or sell their stock.

DERM Shareholders

What type of owners hold Journey Medical Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fortress Biotech Inc14.93%4,110,467$27.21MInsider
Claude Maraoui8.85%2,435,990$16.13MInsider
Wasatch Advisors LP7.75%2,133,370$14.12MInstitution
Tang Capital Management LLC5.85%1,610,000$10.66MInstitution
Vanguard Capital Management LLC3.93%1,082,080$7.16MInstitution
Blackrock Inc3.53%972,862$6.44MInstitution
Opaleye Management Inc3.49%960,000$6.36MInstitution
Ramsey Alloush2.17%598,543$3.96MInsider
J Goldman Co LP1.82%500,188$3.31MInstitution
Pale Fire Capital Se1.75%481,987$3.19MInstitution

1 of 3

DERM vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DERM43.05%31.27%Net Buying
LFCR49.28%50.72%Net SellingNet Selling
ACB9.06%0.00%
OGI5.77%0.00%
CRDL24.92%0.00%

Journey Medical Stock Ownership FAQ

Who owns Journey Medical?

Journey Medical (NASDAQ: DERM) is owned by 43.05% institutional shareholders, 31.27% Journey Medical insiders, and 25.68% retail investors. Fortress Biotech Inc is the largest individual Journey Medical shareholder, owning 4.11M shares representing 14.93% of the company. Fortress Biotech Inc's Journey Medical shares are currently valued at $27.21M.

If you're new to stock investing, here's how to buy Journey Medical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.